<p>Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulators of lung adenocarcinoma (LUAD), yet for many lncRNAs the upstream repressors and downstream effector pathways remain unclear. Here, we identify MIR22HG as a frequently downregulated lncRNA in LUAD, and show that its low expression is associated with aggressive tumor behavior and poor clinical outcome. Functionally, MIR22HG restrains LUAD progression, as evidenced by reduced proliferation, migration, invasion, and xenograft growth upon MIR22HG restoration. Mechanistically, MIR22HG promotes Beclin1-associated autophagy and ferroptosis, providing a functional basis for its tumor-suppressive activity. We further demonstrate that SIN3A serves as an RNA-binding protein that negatively regulates MIR22HG at the post-transcriptional level. SIN3A depletion increases MIR22HG abundance, enhances autophagy- and ferroptosis-related signaling, and suppresses malignant phenotypes in LUAD cells. Importantly, genetic rescue experiments indicate that these SIN3A-dependent effects are partially mediated through MIR22HG, supporting a functional SIN3A–MIR22HG regulatory relationship. Collectively, our data delineate an SIN3A–MIR22HG–Beclin1 regulatory axis that links RNA-level repression to autophagy and ferroptosis control in LUAD and suggest that disruption of this pathway contributes to tumor progression. Targeting SIN3A-mediated repression of MIR22HG may, therefore, represent a potential therapeutic avenue for LUAD.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

SIN3A promotes lung adenocarcinoma by repressing MIR22HG/Beclin1 axis-mediated autophagy and ferroptosis

  • Yongyang Chen,
  • Miao Yin,
  • Xiaobi Huang,
  • Chang Liu,
  • Yuexin Zheng,
  • Honglian Zhou,
  • Xiao Lei,
  • Yuetong Jiang,
  • Yanfeng Liang,
  • Xiaoqing Xu,
  • Quan Yang,
  • Yudong Guo,
  • Haiwen Li,
  • Feiyu Long,
  • Feiyu Niu,
  • Zhixiong Yang,
  • Wenmei Su

摘要

Long noncoding RNAs (lncRNAs) are increasingly recognized as key regulators of lung adenocarcinoma (LUAD), yet for many lncRNAs the upstream repressors and downstream effector pathways remain unclear. Here, we identify MIR22HG as a frequently downregulated lncRNA in LUAD, and show that its low expression is associated with aggressive tumor behavior and poor clinical outcome. Functionally, MIR22HG restrains LUAD progression, as evidenced by reduced proliferation, migration, invasion, and xenograft growth upon MIR22HG restoration. Mechanistically, MIR22HG promotes Beclin1-associated autophagy and ferroptosis, providing a functional basis for its tumor-suppressive activity. We further demonstrate that SIN3A serves as an RNA-binding protein that negatively regulates MIR22HG at the post-transcriptional level. SIN3A depletion increases MIR22HG abundance, enhances autophagy- and ferroptosis-related signaling, and suppresses malignant phenotypes in LUAD cells. Importantly, genetic rescue experiments indicate that these SIN3A-dependent effects are partially mediated through MIR22HG, supporting a functional SIN3A–MIR22HG regulatory relationship. Collectively, our data delineate an SIN3A–MIR22HG–Beclin1 regulatory axis that links RNA-level repression to autophagy and ferroptosis control in LUAD and suggest that disruption of this pathway contributes to tumor progression. Targeting SIN3A-mediated repression of MIR22HG may, therefore, represent a potential therapeutic avenue for LUAD.